Inflammatory and cytotoxic effects of acrolein, nicotine, acetylaldehyde and cigarette smoke extract on human nasal epithelial cells

Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, impor...

Full description

Saved in:
Bibliographic Details
Published inBMC pulmonary medicine Vol. 14; no. 1; p. 32
Main Authors Comer, David M, Elborn, Joseph Stuart, Ennis, Madeleine
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 01.03.2014
BioMed Central
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs). PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method. CSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure time. Acrolein was pro-inflammatory for the PNEC cultures (30 μM exposure for 4 h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50 μM exposure to nicotine for 24 h), and acetylaldehyde was without effect. Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death. Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death predominantly by apoptotic mechanisms.
AbstractList Doc number: 32 Abstract Background: Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs). Methods: PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method. Results: CSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure time. Acrolein was pro-inflammatory for the PNEC cultures (30 μ M exposure for 4 h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50 μ M exposure to nicotine for 24 h), and acetylaldehyde was without effect. Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death. Conclusions: Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death predominantly by apoptotic mechanisms.
Background Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs). Methods PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method. Results CSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure time. Acrolein was pro-inflammatory for the PNEC cultures (30 [mu]M exposure for 4 h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50 [mu]M exposure to nicotine for 24 h), and acetylaldehyde was without effect. Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death. Conclusions Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death predominantly by apoptotic mechanisms. Keywords: Nasal epithelium, Cigarette smoke extract, Acrolein, Nicotine, Acetylaldehyde, Apoptosis
BACKGROUND: Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs). METHODS: PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method. RESULTS: CSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure time. Acrolein was pro-inflammatory for the PNEC cultures (30 μM exposure for 4 h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50 μM exposure to nicotine for 24 h), and acetylaldehyde was without effect. Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death. CONCLUSIONS: Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death predominantly by apoptotic mechanisms.
Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs). PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method. CSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure time. Acrolein was pro-inflammatory for the PNEC cultures (30 [mu]M exposure for 4 h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50 [mu]M exposure to nicotine for 24 h), and acetylaldehyde was without effect. Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death. Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death predominantly by apoptotic mechanisms.
Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs).BACKGROUNDCigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs).PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method.METHODSPNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method.CSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure time. Acrolein was pro-inflammatory for the PNEC cultures (30 μM exposure for 4 h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50 μM exposure to nicotine for 24 h), and acetylaldehyde was without effect. Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death.RESULTSCSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure time. Acrolein was pro-inflammatory for the PNEC cultures (30 μM exposure for 4 h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50 μM exposure to nicotine for 24 h), and acetylaldehyde was without effect. Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death.Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death predominantly by apoptotic mechanisms.CONCLUSIONSAcrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death predominantly by apoptotic mechanisms.
Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette smoke (CS) should be regarded as predominantly responsible for these effects. We hypothesised that acrolein, nicotine and acetylaldehyde, important chemicals contained within volatile cigarette smoke in terms of inducing inflammation and causing addiction, have immunomodulatory effects in primary nasal epithelial cell cultures (PNECs). PNECs from 19 healthy subjects were grown in submerged cultures and were incubated with acrolein, nicotine or acetylaldehyde prior to stimulation with Pseudomonas aeruginosa lipopolysaccharide (PA LPS). Experiments were repeated using cigarette smoke extract (CSE) for comparison. IL-8 was measured by ELISA, activation of NF-κB by ELISA and Western blotting, and caspase-3 activity by Western blotting. Apoptosis was evaluated using Annexin-V staining and the terminal transferase-mediated dUTP nick end-labeling (TUNEL) method. CSE was pro-inflammatory after a 24 h exposure and 42% of cells were apoptotic or necrotic after this exposure time. Acrolein was pro-inflammatory for the PNEC cultures (30 μM exposure for 4 h inducing a 2.0 fold increase in IL-8 release) and also increased IL-8 release after stimulation with PA LPS. In contrast, nicotine had anti-inflammatory properties (0.6 fold IL-8 release after 50 μM exposure to nicotine for 24 h), and acetylaldehyde was without effect. Acrolein and nicotine had cellular stimulatory and anti-inflammatory effects respectively, as determined by NF-κB activation. Both chemicals increased levels of cleaved caspase 3 and induced cell death. Acrolein is pro-inflammatory and nicotine anti-inflammatory in PNEC cultures. CSE induces cell death predominantly by apoptotic mechanisms.
ArticleNumber 32
Audience Academic
Author Ennis, Madeleine
Elborn, Joseph Stuart
Comer, David M
AuthorAffiliation 1 Centre for Infection and Immunity, Health Sciences Building, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK
2 Respiratory Department, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, UK
AuthorAffiliation_xml – name: 1 Centre for Infection and Immunity, Health Sciences Building, School of Medicine, Dentistry and Biomedical Sciences, Queen’s University of Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK
– name: 2 Respiratory Department, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, UK
Author_xml – sequence: 1
  givenname: David M
  surname: Comer
  fullname: Comer, David M
– sequence: 2
  givenname: Joseph Stuart
  surname: Elborn
  fullname: Elborn, Joseph Stuart
– sequence: 3
  givenname: Madeleine
  surname: Ennis
  fullname: Ennis, Madeleine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24581246$$D View this record in MEDLINE/PubMed
BookMark eNp1kstr3DAQxk1JaR7tubci6KWHOLFeflwKaegjEOilPYuxPNpVKktbSxuy9_7hldl0mw0JFniY-c2H9M0cFwc-eCyKt7Q6o7Stz6loaMlEXZdUlJy9KI52mYMH8WFxHONNVdGmlfxVcciEbGkuHBV_rrxxMI6QwrQh4AeiNymkcGc1QWNQp0iCIaCn4ND6U-KtDsl6PM05TBsHbsDlZsBtr13AhCkhiWP4hQTv0gQ6keDJcj2CJx4iOIIrm5bobA41OhdfFy8NuIhv7v8nxc8vn39cfiuvv3-9ury4LnspmlRS5KbrpGy4NBKghZqKfGgrTFsDRaoHoxkdmOiaGirDezq0UlLZy77hbOAnxcet7mrdjzho9Pl6Tq0mO8K0UQGs2q94u1SLcKt4J2RDmyzwaSvQ2_CMwH5Fh1HNU1DzFHKkOMsiH-5vMYXfa4xJjTbOPoDHsI6KyqoWtGGMZ_T9I_QmrCefPZopWTFRdeI_tQCHynoTZtdnUXUheSc71nRdps6eoPI34Jhn6tHYnN9rePfQrd0r_y1PBs63QF6OGCc0O4RWal7PJ54uH3VomyDZMLtl3bN9fwHHL-kr
CitedBy_id crossref_primary_10_1371_journal_pone_0108342
crossref_primary_10_1093_toxsci_kfy226
crossref_primary_10_2174_0929867327666201027152737
crossref_primary_10_1016_j_lfs_2022_120487
crossref_primary_10_1080_15287394_2017_1355863
crossref_primary_10_1016_j_fct_2019_04_034
crossref_primary_10_18632_aging_101264
crossref_primary_10_3389_fmolb_2022_828766
crossref_primary_10_1016_j_intimp_2014_10_029
crossref_primary_10_1016_j_yrtph_2014_12_001
crossref_primary_10_1039_C5TX00477B
crossref_primary_10_1016_j_biopha_2023_115924
crossref_primary_10_1016_j_jcf_2015_11_002
crossref_primary_10_1177_0145561319900758
crossref_primary_10_1183_23120541_00502_2022
crossref_primary_10_12688_f1000research_130430_2
crossref_primary_10_52547_sjimu_30_6_52
crossref_primary_10_1183_16000617_0119_2017
crossref_primary_10_46563_1560_9561_2022_25_5_357_361
crossref_primary_10_3390_ijms24076579
crossref_primary_10_1093_toxsci_kfu233
crossref_primary_10_1007_s00702_023_02703_9
crossref_primary_10_1186_s12890_020_01255_y
crossref_primary_10_1158_1055_9965_EPI_17_0358
crossref_primary_10_1021_acs_chemrestox_3c00197
crossref_primary_10_1080_15287394_2015_1043607
crossref_primary_10_1016_j_tiv_2017_09_016
crossref_primary_10_1186_s12931_018_0722_2
crossref_primary_10_1093_toxsci_kfw051
crossref_primary_10_1186_s13104_020_05337_2
crossref_primary_10_3390_cells12060879
crossref_primary_10_18632_oncotarget_22189
crossref_primary_10_1186_s40779_018_0158_5
crossref_primary_10_3390_ijerph14101221
crossref_primary_10_1016_j_mehy_2017_09_006
crossref_primary_10_4236_odem_2019_71003
crossref_primary_10_1007_s00109_016_1378_3
crossref_primary_10_1016_j_tiv_2015_11_019
crossref_primary_10_1016_j_toxrep_2021_04_007
crossref_primary_10_3390_cells8101287
crossref_primary_10_3389_fimmu_2022_826889
crossref_primary_10_3390_ijerph15051033
crossref_primary_10_1016_j_tox_2018_01_001
Cites_doi 10.1016/S0300-483X(01)00540-6
10.1089/dna.2006.25.312
10.1111/j.1440-1843.2012.02198.x
10.1006/bbrc.1998.9599
10.1126/science.6318317
10.1152/ajplung.90570.2008
10.1074/jbc.M110.204859
10.1165/rcmb.F285
10.1164/ajrccm.155.5.9154890
10.1183/09031936.01.17405960
10.1016/j.rmed.2004.01.010
10.1186/1465-9921-9-7
10.1136/tc.12.4.424
10.1093/ajcn/62.6.1490S
10.1038/35085008
10.1165/rcmb.2002-0235OC
10.1016/S0954-6111(03)00114-8
10.1186/1465-9921-9-66
10.1097/00029330-200706020-00009
10.1016/j.yexcr.2010.09.006
10.1152/ajplung.2001.281.2.L509
10.1155/2010/423241
10.1002/jcp.20825
10.4049/jimmunol.173.6.4164
10.1038/sj.bjp.0707595
10.4049/jimmunol.160.10.5073
10.1186/1465-9921-7-53
10.1165/rcmb.2002-0300OC
10.1165/rcmb.2007-0260OC
10.4196/kjpp.2011.15.6.397
10.2119/2007-00067.Dowling
10.1038/247565a0
10.1165/rcmb.2009-0454OC
10.1165/ajrcmb.27.1.4789
10.2500/ajr.2007.21.3094
10.1016/j.canlet.2008.04.039
10.1165/rcmb.4890
10.1080/14622200500055251
10.1089/ars.2005.7.25
10.1165/rcmb.2008-0131OC
10.1016/j.euroneuro.2007.02.013
10.1001/archotol.126.8.940
10.1007/s11010-007-9411-z
10.2500/ajra.2009.23.3407
10.1371/journal.pone.0032924
10.1124/jpet.103.049262
10.1016/j.trsl.2010.09.001
10.1186/1465-9921-7-132
10.2500/ajr.2007.21.2966
10.1111/j.1572-0241.1999.01059.x
10.1006/taap.1997.8189
10.1186/1465-9921-7-115
10.1080/15412550701341228
ContentType Journal Article
Copyright COPYRIGHT 2014 BioMed Central Ltd.
2014 Comer et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
Copyright © 2014 Comer et al.; licensee BioMed Central Ltd. 2014 Comer et al.; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2014 BioMed Central Ltd.
– notice: 2014 Comer et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
– notice: Copyright © 2014 Comer et al.; licensee BioMed Central Ltd. 2014 Comer et al.; licensee BioMed Central Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7TO
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
H94
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1186/1471-2466-14-32
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Oncogenes and Growth Factors Abstracts
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Publicly Available Content
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
Oncogenes and Growth Factors Abstracts
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
AIDS and Cancer Research Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database



MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2466
EndPage 32
ExternalDocumentID PMC3945717
oai_biomedcentral_com_1471_2466_14_32
3240302061
A539592799
24581246
10_1186_1471_2466_14_32
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
0R~
23N
2WC
4.4
53G
5GY
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
AAYXX
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CITATION
CS3
DIK
DU5
E3Z
EBD
EBLON
EBS
EJD
EMB
EMOBN
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HMCUK
HYE
IAO
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
UKHRP
W2D
WOQ
WOW
XSB
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7TO
7XB
8FK
AZQEC
DWQXO
H94
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
-A0
ABVAZ
ACRMQ
ADINQ
AFGXO
AFNRJ
C24
5PM
ID FETCH-LOGICAL-b547t-1e3f9955735f5aa8a614614184f86a1e1cdfc21d24976a0f3b1d85515b5b732d3
IEDL.DBID RBZ
ISSN 1471-2466
IngestDate Thu Aug 21 14:06:37 EDT 2025
Wed May 22 07:13:22 EDT 2024
Fri Jul 11 04:10:18 EDT 2025
Fri Jul 25 01:15:31 EDT 2025
Tue Jun 17 22:05:08 EDT 2025
Tue Jun 10 21:02:48 EDT 2025
Mon Jul 21 05:45:32 EDT 2025
Tue Jul 01 02:40:09 EDT 2025
Thu Apr 24 23:00:13 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b547t-1e3f9955735f5aa8a614614184f86a1e1cdfc21d24976a0f3b1d85515b5b732d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink http://dx.doi.org/10.1186/1471-2466-14-32
PMID 24581246
PQID 1505024094
PQPubID 44785
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3945717
biomedcentral_primary_oai_biomedcentral_com_1471_2466_14_32
proquest_miscellaneous_1506417223
proquest_journals_1505024094
gale_infotracmisc_A539592799
gale_infotracacademiconefile_A539592799
pubmed_primary_24581246
crossref_primary_10_1186_1471_2466_14_32
crossref_citationtrail_10_1186_1471_2466_14_32
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2014-03-01
PublicationDateYYYYMMDD 2014-03-01
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle BMC pulmonary medicine
PublicationTitleAlternate BMC Pulm Med
PublicationYear 2014
Publisher BioMed Central Ltd
BioMed Central
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
References GJ Jakab (482_CR23) 1977; 115
T Betsuyaku (482_CR15) 2008; 9
Y Hoshino (482_CR31) 2001; 281
H Zhang (482_CR9) 2008; 38
JH Sisson (482_CR29) 1991; 260
H Kim (482_CR32) 2004; 31
C Leuchtenberger (482_CR20) 1974; 247
JP Eiserich (482_CR43) 1995; 62
NJ Roberts (482_CR3) 2003; 97
LJ Manzel (482_CR53) 2011; 44
SD Shapiro (482_CR7) 2004; 31
Y Joe (482_CR47) 2011; 286
P Sarkar (482_CR8) 2007; 301
DM Comer (482_CR35) 2012; 7
Q Li (482_CR41) 2010; 156
IR Witherden (482_CR12) 2004; 30
JR Tsai (482_CR42) 2006; 25
P Montnemery (482_CR5) 2001; 17
B Grasl-Kraupp (482_CR58) 1995; 21
A Richter (482_CR17) 2002; 27
JA Wickenden (482_CR55) 2003; 29
MY Lan (482_CR33) 2007; 21
GJ O’Brien (482_CR34) 2006; 7
WK Lee (482_CR36) 2007; 21
M Leist (482_CR59) 2001; 2
J Fowles (482_CR21) 2003; 12
A Koarai (482_CR13) 2012; 17
G Valacchi (482_CR38) 2005; 7
CM Greene (482_CR40) 2010; 2010
M Nardini (482_CR44) 2002; 170
G Kaushik (482_CR57) 2008; 270
JE Lieu (482_CR6) 2000; 126
SK McMaster (482_CR10) 2008; 153
A Kode (482_CR16) 2006; 7
M Laan (482_CR18) 2004; 173
L Caron (482_CR25) 2005; 7
T Mio (482_CR2) 1997; 155
JH Wang (482_CR11) 2009; 23
H Sugiura (482_CR52) 2007; 210
N Totti 3rd (482_CR26) 1984; 223
O Dowling (482_CR49) 2007; 13
LY Lee (482_CR27) 1955–1961; 1993
S Togo (482_CR51) 2010; 316
AA Floreani (482_CR14) 1998; 160
W Li (482_CR19) 2007; 120
R Talhout (482_CR28) 2007; 17
N Moretto (482_CR39) 2009; 296
C Cohen (482_CR50) 2003; 306
JR Hurst (482_CR4) 2004; 98
N Sugano (482_CR48) 1998; 252
IK Demedts (482_CR30) 2006; 7
CH Yoon (482_CR45) 2011; 15
L Li (482_CR22) 1998; 13
WJ Sandborn (482_CR46) 1999; 94
L Li (482_CR37) 1997; 145
JS Kim (482_CR1) 2007; 4
DL Costa (482_CR24) 1986; 133
X Liu (482_CR54) 2008; 9
DJ Groskreutz (482_CR56) 2009; 41
References_xml – volume: 170
  start-page: 173
  year: 2002
  ident: 482_CR44
  publication-title: Toxicology
  doi: 10.1016/S0300-483X(01)00540-6
– volume: 25
  start-page: 312
  year: 2006
  ident: 482_CR42
  publication-title: DNA Cell Biol
  doi: 10.1089/dna.2006.25.312
– volume: 17
  start-page: 1018
  year: 2012
  ident: 482_CR13
  publication-title: Respirology
  doi: 10.1111/j.1440-1843.2012.02198.x
– volume: 252
  start-page: 25
  year: 1998
  ident: 482_CR48
  publication-title: Biochem Biophys Res Commun
  doi: 10.1006/bbrc.1998.9599
– volume: 223
  start-page: 169
  year: 1984
  ident: 482_CR26
  publication-title: Science
  doi: 10.1126/science.6318317
– volume: 296
  start-page: L839
  year: 2009
  ident: 482_CR39
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.90570.2008
– volume: 286
  start-page: 24735
  year: 2011
  ident: 482_CR47
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M110.204859
– volume: 31
  start-page: 481
  year: 2004
  ident: 482_CR7
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.F285
– volume: 155
  start-page: 1770
  year: 1997
  ident: 482_CR2
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/ajrccm.155.5.9154890
– volume: 17
  start-page: 596
  year: 2001
  ident: 482_CR5
  publication-title: Eur Respir J
  doi: 10.1183/09031936.01.17405960
– volume: 98
  start-page: 767
  year: 2004
  ident: 482_CR4
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2004.01.010
– volume: 9
  start-page: 7
  year: 2008
  ident: 482_CR15
  publication-title: Respir Res
  doi: 10.1186/1465-9921-9-7
– volume: 12
  start-page: 424
  year: 2003
  ident: 482_CR21
  publication-title: Tob Control
  doi: 10.1136/tc.12.4.424
– volume: 62
  start-page: 1490S
  year: 1995
  ident: 482_CR43
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/62.6.1490S
– volume: 133
  start-page: 286
  year: 1986
  ident: 482_CR24
  publication-title: Am Rev Respir Dis
– volume: 2
  start-page: 589
  year: 2001
  ident: 482_CR59
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/35085008
– volume: 29
  start-page: 562
  year: 2003
  ident: 482_CR55
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2002-0235OC
– volume: 97
  start-page: 909
  year: 2003
  ident: 482_CR3
  publication-title: Respir Med
  doi: 10.1016/S0954-6111(03)00114-8
– volume: 9
  start-page: 66
  year: 2008
  ident: 482_CR54
  publication-title: Respir Res
  doi: 10.1186/1465-9921-9-66
– volume: 120
  start-page: 1075
  year: 2007
  ident: 482_CR19
  publication-title: Chin Med J (Engl)
  doi: 10.1097/00029330-200706020-00009
– volume: 316
  start-page: 3501
  year: 2010
  ident: 482_CR51
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2010.09.006
– volume: 281
  start-page: L509
  year: 2001
  ident: 482_CR31
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.2001.281.2.L509
– volume: 2010
  start-page: 423241
  year: 2010
  ident: 482_CR40
  publication-title: Mediators Inflamm
  doi: 10.1155/2010/423241
– volume: 210
  start-page: 99
  year: 2007
  ident: 482_CR52
  publication-title: J Cell Physiol
  doi: 10.1002/jcp.20825
– volume: 173
  start-page: 4164
  year: 2004
  ident: 482_CR18
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.6.4164
– volume: 153
  start-page: 536
  year: 2008
  ident: 482_CR10
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0707595
– volume: 160
  start-page: 5073
  year: 1998
  ident: 482_CR14
  publication-title: J Immunol
  doi: 10.4049/jimmunol.160.10.5073
– volume: 260
  start-page: L29
  year: 1991
  ident: 482_CR29
  publication-title: Am J Physiol
– volume: 13
  start-page: 99
  year: 1998
  ident: 482_CR22
  publication-title: Rev Environ Health
– volume: 7
  start-page: 53
  year: 2006
  ident: 482_CR30
  publication-title: Respir Res
  doi: 10.1186/1465-9921-7-53
– volume: 31
  start-page: 483
  year: 2004
  ident: 482_CR32
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2002-0300OC
– volume: 38
  start-page: 483
  year: 2008
  ident: 482_CR9
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2007-0260OC
– volume: 15
  start-page: 397
  year: 2011
  ident: 482_CR45
  publication-title: Korean J Physiol Pharmacol
  doi: 10.4196/kjpp.2011.15.6.397
– volume: 13
  start-page: 576
  year: 2007
  ident: 482_CR49
  publication-title: Mol Med
  doi: 10.2119/2007-00067.Dowling
– volume: 247
  start-page: 565
  year: 1974
  ident: 482_CR20
  publication-title: Nature
  doi: 10.1038/247565a0
– volume: 44
  start-page: 155
  year: 2011
  ident: 482_CR53
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2009-0454OC
– volume: 27
  start-page: 85
  year: 2002
  ident: 482_CR17
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/ajrcmb.27.1.4789
– volume: 21
  start-page: 1465
  year: 1995
  ident: 482_CR58
  publication-title: Hepatology
– volume: 21
  start-page: 658
  year: 2007
  ident: 482_CR36
  publication-title: Am J Rhinol
  doi: 10.2500/ajr.2007.21.3094
– volume: 270
  start-page: 120
  year: 2008
  ident: 482_CR57
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2008.04.039
– volume: 30
  start-page: 500
  year: 2004
  ident: 482_CR12
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.4890
– volume: 7
  start-page: 181
  year: 2005
  ident: 482_CR25
  publication-title: Nicotine Tob Res
  doi: 10.1080/14622200500055251
– volume: 7
  start-page: 25
  year: 2005
  ident: 482_CR38
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2005.7.25
– volume: 41
  start-page: 189
  year: 2009
  ident: 482_CR56
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2008-0131OC
– volume: 17
  start-page: 627
  year: 2007
  ident: 482_CR28
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2007.02.013
– volume: 115
  start-page: 33
  year: 1977
  ident: 482_CR23
  publication-title: Am Rev Respir Dis
– volume: 1993
  start-page: 75
  year: 1955–1961
  ident: 482_CR27
  publication-title: J Appl Physiol
– volume: 126
  start-page: 940
  year: 2000
  ident: 482_CR6
  publication-title: Arch Otolaryngol Head Neck Surg
  doi: 10.1001/archotol.126.8.940
– volume: 301
  start-page: 191
  year: 2007
  ident: 482_CR8
  publication-title: Mol Cell Biochem
  doi: 10.1007/s11010-007-9411-z
– volume: 23
  start-page: 5
  year: 2009
  ident: 482_CR11
  publication-title: Am J Rhinol Allergy
  doi: 10.2500/ajra.2009.23.3407
– volume: 7
  start-page: e32924
  year: 2012
  ident: 482_CR35
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0032924
– volume: 306
  start-page: 407
  year: 2003
  ident: 482_CR50
  publication-title: J Pharmacol Exp Ther
  doi: 10.1124/jpet.103.049262
– volume: 156
  start-page: 326
  year: 2010
  ident: 482_CR41
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2010.09.001
– volume: 7
  start-page: 132
  year: 2006
  ident: 482_CR16
  publication-title: Respir Res
  doi: 10.1186/1465-9921-7-132
– volume: 21
  start-page: 218
  year: 2007
  ident: 482_CR33
  publication-title: Am J Rhinol
  doi: 10.2500/ajr.2007.21.2966
– volume: 94
  start-page: 1161
  year: 1999
  ident: 482_CR46
  publication-title: Am J Gastroenterol
  doi: 10.1111/j.1572-0241.1999.01059.x
– volume: 145
  start-page: 331
  year: 1997
  ident: 482_CR37
  publication-title: Toxicol Appl Pharmacol
  doi: 10.1006/taap.1997.8189
– volume: 7
  start-page: 115
  year: 2006
  ident: 482_CR34
  publication-title: Respir Res
  doi: 10.1186/1465-9921-7-115
– volume: 4
  start-page: 163
  year: 2007
  ident: 482_CR1
  publication-title: COPD
  doi: 10.1080/15412550701341228
SSID ssj0017853
Score 2.2408967
Snippet Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within cigarette...
Background Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within...
Doc number: 32 Abstract Background: Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various...
BACKGROUND: Cigarette smoke induces a pro-inflammatory response in airway epithelial cells but it is not clear which of the various chemicals contained within...
SourceID pubmedcentral
biomedcentral
proquest
gale
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 32
SubjectTerms Acetaldehyde - adverse effects
Acrolein - adverse effects
Analysis
Apoptosis
Cell culture
Cell death
Cell Death - drug effects
Cells, Cultured
Chemical properties
Chronic obstructive pulmonary disease
Epithelial Cells - drug effects
Health aspects
Humans
Inflammation - chemically induced
Nasal Mucosa - cytology
Nasal Mucosa - drug effects
Nicotiana - adverse effects
Nicotine - adverse effects
Pulmonology
Respiratory diseases
Smoke - adverse effects
Tobacco smoke
SummonAdditionalLinks – databaseName: ProQuest Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k3agoyEBIeabuJHEnFAFaIqSOVEpb1ZjmOrK1JnaVKpe-8P70ziXTYguEWxR3E84_E39jwIecuF94VSJTO2VEx4blklas9mhs-KSnlA5RgofPpdnZyJb3M5jwduXXSrXOvEQVHXrcUz8kMALhLzcZXi0_IXw6pReLsaS2jcJfcwdRlKdT7fGFxYeJ7HdD5poQ5TUMQsE0qxVLCh3sh2iHsz2Zn-1M9bG9TUeXJrNzp-RB5GGEmPRr4_JndceELun8aL8qfk5mvwwOuL4Q6dmlBTu-rbvr1eWBpdOGjrqbHoXbgIBzSARPRAegDvXL9qTFO781XtRtrFUAy3d7S7aH86Cgodg6toG-hQ448G08Fo3BIDPBqQaIr3Ad0zcnb85cfnExYLLrBKirxnqeO-LKXMufTSmMIorPotwAgEfprUpbb2NktrMNlyZWaeV2ldAOSSlaxyntX8OdkJbXAvCS2MMXLmwJgDROZEZirnMyuUA4BUyNwm5ONk8vVyTK6hMd31tAWkQCPrNLIOnjTPEvJhzSptYy5zLKnR6MGmKdTfBO83BOsv_bPrO-S9xgWOk2linAL8F6bK0keSg6RleVkmZH_SExamnTavpUdHxdDp32KckDebZqREZ7fg2quhjxIALDOekBejsG0GnQmJkEwlJJ-I4WT-pi1hcT6kDeelkGC87_5_WHvkAWBCMbrZ7ZOd_vLKvQLc1Vevh8V1C68JLw8
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBYlhdJLSd_Oo6hQaA9RurYetiihhNKQFranLuQmZFkiSx05zTqQveeHd8b2buI07W2xNF5Z8400w7wIecdFCIVSmlmnFROBO1aKKrCJ5ZOiVAG0ckwUnv5QxzPx_USe3LQDGjZwca9ph_2kZhf1_tXv5WcQ-INO4Av1MYUDlmVCKZYKxuE8fgjXUo7tDKbixqWQF11JyvXkoc7PPS-4k_tej66suwf3rZtrHFV565o62iRPBv2SHvaAeEoe-PiMPJoOHvTn5PpbDACCs865Tm2sqFu2TdtczR0dYjtoE6h1GHY4j3s0AlRaIN2DZ75d1rau_Omy8j3tvOuS23q6OGt-eQonPWZd0SbSrvkfjXYBq_HnmPlRA9QpOgoWL8js6OvPL8ds6MTASinylqWeB62lzLkM0trCKmwHLsA6BEbb1KeuCi5LK7DlcmUngZdpVYAuJktZ5jyr-EuyEZvoXxNaWGvlxIOVB6qaF5ktfcicUB40p0LmLiGfRptvzvuqGwbrYI9HQCQNss4g6-CX4VlC9lesMm4oco69NmrTGTuF-pvgw5pg9U__nPoeeW8Qi7iZdkhggO_CGlrmUHItdZZrnZCd0UyQWDceXqHHrABvQDGXWG9Oi4S8XQ8jJUbBRd9cdnMUIjvjCXnVg2296ExI1NVUQvIRDEf7Nx6J89OunjjXQoJVv_X_VW-Tx6Asij7-bodstBeXfhcUsrZ80wnaHwgZMxo
  priority: 102
  providerName: Scholars Portal
Title Inflammatory and cytotoxic effects of acrolein, nicotine, acetylaldehyde and cigarette smoke extract on human nasal epithelial cells
URI https://www.ncbi.nlm.nih.gov/pubmed/24581246
https://www.proquest.com/docview/1505024094
https://www.proquest.com/docview/1506417223
http://dx.doi.org/10.1186/1471-2466-14-32
https://pubmed.ncbi.nlm.nih.gov/PMC3945717
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFLdgkxAXxDeBURkJCQ4zNP6OOG1o00DqhBCTKi6W49haReZMNJPonT-c5yQtS4ETlyqq_ZLU7_n59_q-EHrJeAhayoJYV0jCA3Ok5FUgU8umupQBUHlKFJ6dypMz_nEu5r-LRW958HMt3-agPgnlUpKcEwbadpdysOeSYX74deMwULorOLmZPFTx-csNtjLb69GBtK2Wr51L45jJa4fQ8V10Z0CP-KBn9z10w8f76NZs8I8_QD8_xAAsvuhc59jGCrtV27TNj4XDQ-QGbgK2LgUVLuI-jiAILZDuw3e-XdW2rvz5qvI97aLrgdt6vLxovnkMejzlVOEm4q61H452CW_jL1NeRw2CjJMbYPkQnR0ffXl_QoY-C6QUXLUk9ywUhRCKiSCs1VamZt8cbD9go8197qrgaF6BpaaknQZW5pUGpCVKUSpGK_YI7cQm-icIa2utmHqw4QCIeU5t6QN1XHrARVool6F3o8U3l31NDZOqXI9HYMOZxDqTWAdXhtEMvVmzyrihhHnqpFGbzpTR8k-C1xuC9ZP-OfVV4r1J-zotph3SE-B3pQpZ5kCwQhRUFUWG9kYzYT-68fBaesygD5YGYLdI1eQKnqEXm-FEmWLcom-uujmSA56kLEOPe2HbvDTlIiExmSE1EsPR-o1H4uK8qxbOCi7AZn_6Xyv_DN0GpMj74Ls9tNN-v_LPAY215QTdVHM1QbuHR6efPk-6_zTgc8b1pNuhvwAVNzYH
linkProvider BioMedCentral
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXxDcZA4wEgoeZNfFHEiGEJmBq2bqnTeqbcRxbq-iSjmaCvvP38Ddyl4_SgOBtb1XsS13f-e539X0Q8pwL7xOlUmZsqpjw3LJM5J4NDB8kmfKAyjFReHykhifi00RONsjPLhcGwyo7nVgr6ry0-B_5LgAXifW4UvFufs6waxTernYtNBqxOHDLb-CyLd6OPgB_X0TR_sfj90PWdhVgmRRxxULHfZpKGXPppTGJUdjaWoCnA4s2oQtt7m0U5uCXxMoMPM_CPAFcITOZxTzKObz3CrkKhneAzl48WTl42Oiet-WDwkTthqD4WSSUYqFgdX-T9ZT6Wc8S_mkP1gxiP1hzzfrt3yI3W9hK9xo5u002XHGHXBu3F_N3yY9R4UG2zuo7e2qKnNplVVbl96mlbcgILT01FqMZp8UOLUACKyDdgWeuWs7MLHeny9w1tNO6-W7l6OKs_OIoGBBM5qJlQeuegrQwC1iNm2NCyQxOEMX7h8U9cnIprLhPNouycA8JTYwxcuDAeQQE6ERkMucjK5QDQJbI2AbkTW_z9bwp5qGxvHZ_BKROI-s0sg4-aR4F5HXHKm3b2unYwmOmax8qUX8TvFoRdN_0z6kvkfcaFQpupmnzIuB3YWkuvSd5KtMoTtOAbPdmgiKw_eFOenSriBb697EJyLPVMFJicF3hyot6jhIAZCMekAeNsK0WHQmJEFAFJO6JYW__-iPF9LQuU85TIeMw3vr_sp6S68Pj8aE-HB0dPCI3AI-KJsRvm2xWXy_cY8B8VfakPmiUfL7sk_0L0OJqkg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELaqIlVcEG8CBYyEBIe63cSPxOJUHqsWaFUhKlVcLMex1VWzzqqbldg7P5xxXtoUOHGLYk8eM-PxN_I8EHpNmXOZEJJoIwVhjhqSs8KRiaaTLBcOUHlIFD45FUfn7PMFv9hCZ30uTD43i1UJEtDX6_50eX8zE71szDdcmKuDReHaVZ-JgxisLEmYECRmhIJRvpVynoaeBt_e_xjOFdKsqUs5TO6K_fzlATcS4MvRvnXTem9sX-PQyo29anoX3elAJj5steIe2rL-Pto56X70Afp17B1owrw5YcfaF9is66qufs4M7gI8cOWwNiH2cOb3sAd9qYF0D-7Zel3qsrCX68K2tLOmVW5t8XJeXVkM5j6kXuHK46YDIPZ6CV9jFyH9owR9x-G0YPkQnU8_ff9wRLp2DCTnLK1JbKmTEphKueNaZ1qEnuAMXESQto5tbApnkrgAhy4VeuJoHhcZADKe8zylSUEfoW1fefsE4UxrzScWXD3Aa5YlOrcuMUxYgE8ZT02E3o2YrxZt6Q0VimGPR0AbVBCdCqKDK0WTCO33olKmq3QeGm6UqvF4MvEnwduBoH_TP6e-CbJXYfkHZuouiwH-KxTSUoecSi6TVMoI7Y5mwrI14-Fee1RnNpYK0DkPRecki9CrYThQhlA4b6tVM0cwgJ0JjdDjVtmGj04YD4BNRCgdqeGIf-MRP7tsiopTyTi49k__i_Mv0c7Zx6n6enz65Rm6DdiSteF6u2i7vl7Z54Df6vxFsyR_A1VORCI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inflammatory+and+cytotoxic+effects+of+acrolein%2C+nicotine%2C+acetylaldehyde+and+cigarette+smoke+extract+on+human+nasal+epithelial+cells&rft.jtitle=BMC+pulmonary+medicine&rft.au=Comer%2C+David+M&rft.au=Elborn%2C+Joseph+Stuart&rft.au=Ennis%2C+Madeleine&rft.date=2014-03-01&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2466&rft.eissn=1471-2466&rft.volume=14&rft_id=info:doi/10.1186%2F1471-2466-14-32&rft.externalDocID=A539592799
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2466&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2466&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2466&client=summon